110409 ⎘
Reverse transcribing RNA viruses; Details; Retroviridae; Human Immunodeficiency Virus, HIV; Methods of inactivation or attenuation by chemical treatment
METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#2METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#3METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#4METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#5Methods and compositions for RNA-guided treatment of HIV infection
#6Environmentally compatible detergents for inactivation of lipid-enveloped viruses
#7Alkaloids from sponge, scaffolds for the inhibition of human immunodeficiency virus (HIV)
#8Polyclonal antibodies produced using HIV-1 trimeric envelope glycoprotein subunits
#9Anti-Viral Azide Containing Compounds
#10METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#11METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#12METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#13METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#14METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#15Methods and compositions for RNA-guided treatment of HIV infection
#16METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#17METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#18METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#19METHODS AND COMPOSITIONS FOR RNRA-GUIDED TREATMENT OF HIV INFECTION
#20METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#21METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#22METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#23METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#24METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#25Methods and compositions for RNA-guided treatment of HIV infection
#26METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#27INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
#283-hydroxypyrimidine-2,4-dione-5-carboxamides as potent inhibitors of HIV
#29Alkaloids from sponge, scaffolds for the inhibition of human immunodeficiency virus (HIV)
#30Methods for modular synthesis of N-glycans and arrays thereof
#31Anti-viral azide containing compounds
#32Method of producing an inactivated lentivirus, especially HIV, vaccine, kit and method of use
#33Methods and compositions for RNA-guided treatment of HIV infection
#34COMPOSITIONS AND METHODS FOR INHIBITING VIRAL ACTIVITY
#35Methods and compositions for RNA-guided treatment of HIV infection
#36METHODS FOR TREATING VIRAL INFECTIONS
#37Neutralizing antibodies that bind to the HIV-1 Env V2 critical neutralization domain
#38ANTI-VIRAL AZIDE-CONTAINING COMPOUNDS
#39Anti-Viral Azide Containing Compounds
#40Methods for Inactivating Viruses
#41HIV-1 Peptides, Nucleic Acids, and Compositions and Uses Thereof
#42Screening assays for compounds that modulate programmed ribosomal frameshifting
#43Methods for treating spinal muscular atrophy
#44METHODS FOR TREATING AIDS
#45Cellular and viral inactivation
#46Preparation of vaccines using photosensitizer and light
#47Cellular and viral inactivation
#48Inactivated influenza virus compositions
#49Immunizing compositions comprising nucleic acids encoding the HIV-1 matrix protein myristate binding site
#50Method of making immunogenic compositions comprising UV-irradiated, psoralen-inactivated, desialated human immunodeficiency virus (HIV) particles devoid of CD55 and CD59 in the viral membrane
#51Method of inducing an immune response in a host by administering immunogenic compositions comprising UV-irradiated, psoralen-inactivated, desialated human immunodeficiency virus (HIV) particles devoid of CD55 and CD59 in the viral membrane
#52Immunizing compositions comprising recombinant attenuated self-replicating viral RNA replicons encoding an epitope obtained from the HIV-1 matrix protein myrstate binding site
#53Nucleic acid amplification controls
#54Nucleic acid amplification controls
#55Vaccine and Method of Use
#56Preparation of Vaccines Using Photosensitizers and Light
#57Compositions and methods of treating retroviral infections
#58Preparation of vaccines using a photosensitizer and light
#59Subtype-matched inactivated whole virus vaccines for treating patients with HIV infection
#60Immunogenic composition and method of developing a vaccine based on fusion protein
#61Immunizing compositions encoding an epitope obtained from the HIV-1 capsid protein cyclophilin A binding site
#62Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA
#63Immunogenic compositions comprising UV-irradiated, psoralen-inactivated, desialated human immunodeficiency virus (HIV) devoid of CD55 and CD59 in the viral membrane
#64Immunogenic compositions capable of eliciting Th1 immune responses comprising an HIV-1 MA myristate binding site polypeptide
#65Immunogenic composition and method of developing a vaccine based on factor H binding sites